
Currently out of the existing stock ratings of Rajan Sharma, 5 are a HOLD (23.81%), 11 are a BUY (52.38%), 5 are a SELL (23.81%).
Analyst Rajan Sharma, currently employed at GOLDMAN SACHS, has had 41.67% of price targets met with an average potential upside of 64.38%, reached in 137 days on average. Previously, Rajan Sharma worked at DEUTSCHE BANK.
Rajan Sharma has documented 35 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on DBVT, DBV Technologies at 09-Apr-2026.
Analyst best performing recommendations are on MOR (MORPHOSYS AG ADR).
The best stock recommendation documented was for MOR (MORPHOSYS AG ADR) on 11/22/2023. The price target of $19.13 was fulfilled within 176 days with a profit of $14.58 (320.44%), with a performance score of 18.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Dec-2019
$240
$55.55 (30.12%)
$105
7 months 21 days ago
(30-Mar-2026)
12/15 (80%)
$47.4 (24.61%)
572
Buy Since 27-Jan-2020
$220
$35.55 (19.27%)
$174
7 months 24 days ago
(27-Mar-2026)
5/16 (31.25%)
$32.82 (17.53%)
570
Buy Since 11-Apr-2023
$109
$-75.45 (-40.91%)
$168
8 months 18 days ago
(02-Mar-2026)
1/3 (33.33%)
$-93.39 (-46.14%)
128
Buy Since 26-Jan-2018
$108.5
$-75.95 (-41.18%)
11 months 26 days ago
(25-Nov-2025)
6/7 (85.71%)
$-74.82 (-40.81%)
856
Hold Since 27-Oct-2025
1 years 24 days ago
(27-Oct-2025)
2/3 (66.67%)
$-6.12 (-4.81%)
958
What Year was the first public recommendation made by Rajan Sharma?